Login

Kyndryl CEO Martin Schroeter shared his insights on a significant day shortly after the Opening Bell. 00:10:00

Share On Facebook Share On Twitter

Martin J Schroeter is Chairman/CEO at Kyndryl Holdings Inc. 

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
The Best VC Pitches Gets Right to the Point|Nick Adams,Co-Founder, Managing Partner,Differential Ventures
00:10:00
Rabobank CEO's Commitment to Responsible Banking Principles | Wiebe Draijer, CEO, Rabobank.
00:10:00
Roth IRA vs. Traditional IRA: Which Should You Choose? | PHILIP FRANCOIS - CERTIFIED FINANCIAL PLANNER, Owner & Financial Planner of Foundation Wealth Planning
00:10:00
AI Interfaces and the Future of MLOps with Tristan Zajonc | Tristan Zajonc, CEO , Continual Ltd.
00:10:00
Fintech & Crypto Seed Investing |Jared Franklin,Vice President,Costanoa Ventures
00:10:00
KBC Bank's Strong Financial Performance and Strategic Milestones | Johan Thijs, CEO, KBC Bank.
00:10:00
Sommet BFM patrimoine/CNCGP – Gay-Lussac Gestion | Louis de FELS, MD, Gay-Lussac Gestion SAAS OF 30 JUN 2023
00:10:00
Top Absolute Return Performers: Fatima Khizou’s Picks for Consistent Gains Across Market Cycles | Fatima Khizou - Fund Analyst, Morningstar
00:10:00
Celebrating 50 Years of Datalogic: A Journey of Innovation and Passion
00:10:00
Exclusive Interview with AGI CEO Kevin Andrew Tan | Kevin Andrew L. Tan - Chief Executive Officer & Vice Chairman of Alliance Global
00:10:00
Panel Highlights the Shift to Pre-Trade and Intra-Trade Best Execution Analysis
00:10:00
Nordea's Resilience and Strong Performance in 2023 | Frank Vang-Jensen, CEO, Nordea .

© 2017 - Neuhu+